Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells

Table 2 Relationship between the expression of BCL9 and clinicopathological parameters of epithelial ovarian cancer

Feature	n	Negative	Positive	P	Low	High	P
Age (years)	61			1.000			0.412
< 50	11	2	9		7	4
≥ 50	50	9	41		25	25
Pathological type	61			0.778			0.134
Serous	49	8	41		24	6
Other	26	3	9		3	9
FIGO stage	61			0.139			0.210
I–II	24	7	17		13	11
III–IV	37	4	33		14	23
Differentiation	61			0.288			0.080
Well/moderate	22	6	16		13	9
Poor	39	5	34		14	25
Lymphatic	48			0.334			0.424
No	35	9	26		18	17
Yes	13	1	12		5	8

ISSN: 1475-2867